USD 154.07
(-1.97%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 1.7 Billion USD | 3.11% |
2022 | 1.65 Billion USD | 3570.31% |
2021 | 45.04 Million USD | -13.62% |
2020 | 52.14 Million USD | 43.82% |
2019 | 36.25 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
1997 | - USD | 0.0% |
1996 | - USD | 0.0% |
1995 | - USD | 0.0% |
1994 | - USD | 0.0% |
1993 | - USD | 0.0% |
1992 | - USD | 0.0% |
1991 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 1.68 Billion USD | -1.03% |
2024 Q2 | 1.67 Billion USD | -0.47% |
2023 FY | 1.7 Billion USD | 3.11% |
2023 Q4 | 1.7 Billion USD | 4.27% |
2023 Q3 | 1.63 Billion USD | -0.38% |
2023 Q2 | 1.64 Billion USD | -0.37% |
2023 Q1 | 1.64 Billion USD | -0.37% |
2022 Q4 | 1.65 Billion USD | -4.84% |
2022 Q3 | 1.73 Billion USD | -0.45% |
2022 Q1 | 1.75 Billion USD | 3789.46% |
2022 FY | 1.65 Billion USD | 3570.31% |
2022 Q2 | 1.74 Billion USD | -0.39% |
2021 FY | 45.04 Million USD | -13.62% |
2021 Q2 | 48.76 Million USD | -3.99% |
2021 Q3 | 46.26 Million USD | -5.12% |
2021 Q4 | 45.04 Million USD | -2.64% |
2021 Q1 | 50.79 Million USD | -2.6% |
2020 Q3 | 53.24 Million USD | -74.01% |
2020 Q1 | 150 Million USD | 313.7% |
2020 Q2 | 204.82 Million USD | 36.55% |
2020 FY | 52.14 Million USD | 43.82% |
2020 Q4 | 52.14 Million USD | -2.06% |
2019 Q3 | 36.94 Million USD | -1.42% |
2019 Q4 | 36.25 Million USD | -1.85% |
2019 Q1 | 38.6 Million USD | 0.0% |
2019 Q2 | 37.47 Million USD | -2.93% |
2019 FY | 36.25 Million USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q3 | 1.93 Million USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q4 | - USD | -100.0% |
2017 Q3 | 75 Million USD | 0.0% |
2017 Q2 | 75 Million USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | -100.0% |
2017 Q1 | 75 Million USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2000 FY | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 Q1 | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
1999 Q1 | - USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1999 Q2 | - USD | 0.0% |
1998 Q3 | - USD | 0.0% |
1998 FY | - USD | 0.0% |
1998 Q1 | - USD | 0.0% |
1998 Q2 | - USD | 0.0% |
1998 Q4 | - USD | 0.0% |
1997 Q3 | - USD | 0.0% |
1997 Q1 | - USD | 0.0% |
1997 Q4 | - USD | 0.0% |
1997 Q2 | - USD | 0.0% |
1997 FY | - USD | 0.0% |
1996 Q1 | - USD | 0.0% |
1996 Q2 | - USD | 0.0% |
1996 Q3 | - USD | 0.0% |
1996 FY | - USD | 0.0% |
1996 Q4 | - USD | 0.0% |
1995 Q2 | 400 Thousand USD | 0.0% |
1995 Q1 | - USD | 0.0% |
1995 FY | - USD | 0.0% |
1995 Q4 | - USD | 0.0% |
1995 Q3 | - USD | -100.0% |
1994 Q2 | - USD | 0.0% |
1994 FY | - USD | 0.0% |
1994 Q1 | - USD | 0.0% |
1994 Q3 | - USD | 0.0% |
1994 Q4 | - USD | 0.0% |
1993 Q1 | - USD | 0.0% |
1993 Q2 | - USD | 0.0% |
1993 Q3 | - USD | 0.0% |
1993 Q4 | - USD | 0.0% |
1993 FY | - USD | 0.0% |
1992 FY | - USD | 0.0% |
1992 Q1 | - USD | 0.0% |
1992 Q4 | - USD | 0.0% |
1992 Q2 | - USD | 0.0% |
1992 Q3 | - USD | 0.0% |
1991 Q4 | - USD | 0.0% |
1991 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 85.7 Million USD | -1889.029% |
AngioDynamics, Inc. | 5.91 Million USD | -28725.11% |
AtriCure, Inc. | 74.49 Million USD | -2188.395% |
Avinger, Inc. | 15.39 Million USD | -10973.186% |
Azenta, Inc. | 60.43 Million USD | -2720.698% |
BioLife Solutions, Inc. | 42.69 Million USD | -3893.153% |
The Cooper Companies, Inc. | 2.56 Billion USD | 33.648% |
Daxor Corporation | 755.65 Thousand USD | -225493.422% |
Ekso Bionics Holdings, Inc. | 7.16 Million USD | -23682.324% |
Femasys Inc. | 6.7 Million USD | -25340.188% |
GlucoTrack, Inc. | 196 Thousand USD | -869653.571% |
Harvard Bioscience, Inc. | 42.77 Million USD | -3885.498% |
Hologic, Inc. | 2.53 Billion USD | 32.742% |
Intuitive Surgical, Inc. | 89.8 Million USD | -1798.349% |
KORU Medical Systems, Inc. | 4.44 Million USD | -38250.303% |
LeMaitre Vascular, Inc. | 19.09 Million USD | -8827.557% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 970 Million USD | -75.744% |
Microbot Medical Inc. | 231 Thousand USD | -737872.727% |
Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -23153.115% |
Merit Medical Systems, Inc. | 891.35 Million USD | -91.249% |
Nephros, Inc. | 1.83 Million USD | -92749.51% |
NovoCure Limited | 596.24 Million USD | -185.91% |
NEXGEL, Inc. | 2.79 Million USD | -60826.269% |
NEXGEL, Inc. | 2.79 Million USD | -60826.269% |
Singular Genomics Systems, Inc. | 75.28 Million USD | -2164.261% |
OraSure Technologies, Inc. | 13.5 Million USD | -12523.793% |
Pro-Dex, Inc. | 13.54 Million USD | -12483.723% |
Pulse Biosciences, Inc. | 9.14 Million USD | -18543.012% |
Predictive Oncology Inc. | 2.85 Million USD | -59571.963% |
Precision Optics Corporation, Inc. | 3.43 Million USD | -49535.649% |
QuidelOrtho Corporation | 2.61 Billion USD | 34.788% |
Repligen Corporation | 711.8 Million USD | -139.492% |
Sanara MedTech Inc. | 11.79 Million USD | -14356.42% |
STAAR Surgical Company | 35.83 Million USD | -4657.261% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 342 Thousand USD | -498355.263% |
DENTSPLY SIRONA Inc. | 2.29 Billion USD | 25.85% |
Jin Medical International Ltd. | 4.11 Million USD | -41347.046% |